Welcome to HFMedChoice.com

This tool is intended to assist clinicians and their patients in discussions on the potential benefits and harms of medical therapies for heart failure (HF).

Demographics

Age
 years
Sex
Weight
 kg
Height
 cm
BMI

HF Information

HF Duration
 months
NHYA Class
Ejection Fraction
 %
HF hospitalizations (within last 12 months)

Medical History & Labs

Diabetes
Current smoker
COPD
Systolic BP
 mmHg
Serum creatinine
 umol/L
NT-proBNP
 ng/L
Serum sodium
 mmol/L
Hemoglobin
 g/L
eGFR
 mL/min/1.73 m2

Current HF Therapies

ACEI, ARB, ARNI
Beta blocker
Spironolactone/eplerenone
Furosemide
Device
Statin

Risk of dying within 1 year:

Current

N/A

With Therapy

N/A
N/A
No Event Treatment Benefit Event

Possible Side Effects

Displayed percentages represent the absolute risk increase compared to placebo (except for sacubitril-valsartan, which was compared to ACE inhibitor). Only differences found to be statistically significant in randomized controlled trials are shown.

No treatment selected

Other Treatment Information

No treatment selected

HFMedChoice is a decision support tool intended for use by healthcare professionals. It is not meant to be a substitute for professional advice.
Version 2020.1 - © 2020 Ricky Turgeon